Veera Baladandayuthapani

Veera Baladandayuthapani

University of Michigan - Ann Arbor / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1295339
person_outline Veera Baladandayuthapani's MOST POPULAR ARTICLES
1-) Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trialJR Westin, F Chu, M Zhang, LE Fayad, LW Kwak, N Fowler, J Romaguera, ...The lancet oncology 15 (1), 69-77, 20146122014
2-) Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trialNH Fowler, RE Davis, S Rawal, L Nastoupil, FB Hagemeister, ...The Lancet Oncology 15 (12), 1311-1318, 20142642014
3-) Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myelomaDJ Kuhn, Z Berkova, RJ Jones, R Woessner, CC Bjorklund, W Ma, ...Blood, The Journal of the American Society of Hematology 120 (16), 3260-3270, 20121932012
4-) Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with …S Prasad, VR Yadav, B Sung, S Reuter, R Kannappan, A Deorukhkar, ...Clinical cancer research 18 (18), 4942-4953, 20122042012
5-) Phase I clinical trial of systemically administered TUSC2 (FUS1)-nanoparticles mediating functional gene transfer in humansC Lu, DJ Stewart, JJ Lee, L Ji, R Ramesh, G Jayachandran, MI Nunez, ...PloS one 7 (4), e34833, 20122012012